Skip to main content

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma

The Original Article was published on 21 November 2018

Correction to: BMC Cancer

As a result of an author oversight in the original article [1], the legend of Figure 5A and C is inaccurate and one panel in Figure 5C (FOXM1N H929 cells shown in the top row, left) is wrong. The mistakes have now been corrected in Figure 5C appended below and in the amended legend to Figure 5A and C below. Importantly, the main text of the paper and the results and conclusions described therein are not affected by this correction. We sincerely apologize to the readership of BMC Cancer for any confusion the oversight may have caused.

figure a

Amended legend to Figure 5:

(A) Western analysis of Rb and pRb levels in paired FOXM1Hi and FOXM1N myeloma cells (left) and paired FOXM1KD and FOXM1N myeloma cells (right).

(C) Depicted to the left is the elevation of β-galactosidase (β-gal) activity, a classic phenotype of cellular senescence, in FOXM1KD H929 cells (bottom) relative to FOXM1N controls (top). Cells were not treated with drug in both cases. The result was confirmed using paired FOXM1KD / FOXM1N ARP1 samples (not shown). Depicted to the right is the increased proportion of β-gal+ XG1 cells following treatment with Dox. FOXM1Hi cells exhibited a lesser increase than FOXM1N cells. Cells were evaluated using an Olympus BX-51 Light Microscope equipped with an UPLSAPO objective (Olympus) of 40x magnification and 0.95 numerical aperture. The imaging medium was air. The light temperature of the microscope bulb varied between 3000 and 3400 K. Images were acquired with the help of a DP2 digital camera (Olympus) and DP2-BSW imaging software (Olympus), saved as TIF data files, and enhanced—with respect to brightness, contrast, and color balance—using the Adobe Photoshop CS2 Version 9.0.2 software (Adobe Systems, Inc).


  1. Gu, et al. Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma. BMC Cancer. 2018;18:1152

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Ye Yang or Siegfried Janz.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gu, C., Jing, X., Holman, C. et al. Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma. BMC Cancer 19, 1238 (2019).

Download citation

  • Published:

  • DOI: